Plesk 12.0.18 for Microsoft Windows Logged in as parulganju Subscription Help Search... Submit Websites & DomainsApplicationsFilesStatisticsAccount Edit the File \ / \ /httpdocs / aboutus.html View the original file in the following encoding: Reload Warning: Any unsaved changes will be lost on reloading the file. AHAMMUNE BIOSCIENCES PVT LTD


  • Ahammune Biosciences Pvt. Ltd. is a startup company based in Pune, India recognized by the Department of Industrial Policy & Promotion (DIPP). The company’s R&D center is located at NCL Innovation Park.
  • Ahammune Biosciences is an innovation-led drug discovery company started in 2016 which focuses on developing new treatment options for immune mediated diseases of the skin. Our current program is on the depigmenting disorder, Vitiligo.
  • The current treatments for Vitiligo provide only temporary and symptomatic relief. Thus, there is an enormous unmet global need in treating patients with Vitiligo. The mission of Ahammune Biosciences is to arrest the progress of Vitiligo and to induce re-pigmentation of depigmented patches.
  • In this socially-conscious endeavor, Ahammune has received support from the government in the form of tax-exemption for 3 years on capital gains.
  • We are committed to take our innovation-driven drug discovery platform to the next level to demonstrate to the world that we as a nation can foster new molecules for complex diseases.

Founded by Dr. Krishnamurthy Natarajan and Dr. ParuI Ganju, Ahammune Biosciences boasts of a highly experienced and skilled founding team. The team brings together both scientific discovery and development expertise in the dermatology arena.


Prof P. Balaram
(Non-Executive Director)
Dr Krishnamurthy Natarajan
(Co-founder, Non-Executive Director)
Dr. Satyajit Rath
(Non-Executive Director)

Gautham Nadig
(Non-Executive Director)
Dr Parul Ganju
(Co-founder, Executive Director)


Dr Sudhanand Prasad (Director-R&D)

Dr. Prasad is Director, R&D at Ahammune. Prior to joining the Company, he served as the Director of R&D at Vyome Biosciences, a Delhi based innovation driven company focusing on Dermatology research. He has more than 2 decades of research experience in academia as well as pharmaceutical industry. He has also been the General Manager of Biopharmaceutical Research of Panacea Biotec, New Delhi. He has served as the Joint Director; New Drug Discovery Research at Dabur Research Foundation, with focus in the area of development of peptide based new drugs for cancer, diabetes other metabolic disorders. He has 15 US patents and more than 40 patents in the rest of the world to his credit and over 30 research publications in reputed international journals. Dr. Prasad obtained his Ph.D. in Chemistry from the Banaras Hindu University in collaboration with the Indian Institute of Science, Bangalore. He also worked as postdoctoral fellow at Indian Institute of Science, Bangalore and Research Scientist at International Centre for Genetic Engineering & Biotechnology, New Delhi.

Dr. Mahesh Kumar Verma (Assistant Director- Biology)

Dr. Verma works as an Assistant Director-Biology at Ahammune. He has 8 years of experience in the field of drug discovery and successfully led multiple drug discovery programs across various therapeutic areas in companies like Connexios Life Sciences and Adivinus Therapeutics in Bangalore. These programs are out-licensed to big pharma and ready for human clinical trials. He found and validated novel targets for T2DM, NASH and liver fibrosis and initiated the full-fledged discovery programs on these targets. He has worked on various targets including GPCRs, nuclear receptors, enzymes and kinases. He has published 10 original research articles in international journals and filed many patents.

Kashinath K. (Group Leader- Chemistry)

Dr. K. Kashinath has completed his Ph.D. from CSIR-National Chemical Laboratory, Pune, under the guidance of Dr. D. Srinivasa Reddy in 2016 and joined Ahammune Biosciences. Prior to joining the doctorate program, he worked as an associate research scientist in Advinus Therapeutics, Pune for 18 months. Kashinath is an author of 10 publications and is a reviewer for Elsevier publications on Bioorganic and Medicinal Chemistry Letters. He is a recipient of Best Research Scholar- Keerthi Sangoram Memorial Endowment Award -2014.

Save in the following encoding: Line break type: Reset Save Save As OK Cancel Submit © 2015 Parallels IP Holdings GmbH. All rights reserved. Odin and the Odin logo are trademarks of Parallels IP Holdings GmbH.